Abstract
This review covers literature on non-stabilized functionalized organolithium compounds since 1997. In this overview, we consider intermediates with different separation between the functional group and the carbonlithium bond (dn-reagents) and having different hybridization at the carbanionic centre. Special emphasis is given to the synthetic applications of these intermediates in order to prepare polyfunctionalized molecules.
Keywords: Organolithium Compounds, polyfunctionalized molecules
Current Organic Chemistry
Title: Functionalized Organolithium Compounds: New Synthetic Adventures
Volume: 7 Issue: 9
Author(s): Carmen Najera and Miguel Yus
Affiliation:
Keywords: Organolithium Compounds, polyfunctionalized molecules
Abstract: This review covers literature on non-stabilized functionalized organolithium compounds since 1997. In this overview, we consider intermediates with different separation between the functional group and the carbonlithium bond (dn-reagents) and having different hybridization at the carbanionic centre. Special emphasis is given to the synthetic applications of these intermediates in order to prepare polyfunctionalized molecules.
Export Options
About this article
Cite this article as:
Najera Carmen and Yus Miguel, Functionalized Organolithium Compounds: New Synthetic Adventures, Current Organic Chemistry 2003; 7 (9) . https://dx.doi.org/10.2174/1385272033486675
DOI https://dx.doi.org/10.2174/1385272033486675 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Aptamers: Potential Applications to Pancreatic Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Nutraceuticals and Dietary Supplements to Improve Quality of Life and Outcomes in Heart Failure Patients
Current Pharmaceutical Design Studies on Coumarins and Coumarin-Related Compounds to Determine their Therapeutic Role in the Treatment of Cancer
Current Pharmaceutical Design Urinary Tract Infection. Why Do Some Children Get Complications, While Others Dont?
Current Pediatric Reviews Development of a Simple Fed-Batch Process for the High-Yield Production of Recombinant Shiga Toxin B-Chain Protein
Protein & Peptide Letters Mechanistic Insights into the Antileukemic Activity of Hyperforin
Current Cancer Drug Targets Signal Transduction in Human Cutaneous Melanoma and Target Drugs
Current Cancer Drug Targets Preface
Recent Patents on Anti-Infective Drug Discovery New Treatment Strategies for Multiple Myeloma by Targeting BCL-2 and the Mevalonate Pathway
Current Pharmaceutical Design Targeted Radionuclide Therapy - An Overview
Current Radiopharmaceuticals Novel Biomarkers for Risk Stratification and Identification of Lifethreatening Cardiovascular Disease: Troponin and Beyond
Current Cardiology Reviews Recent Developments in Pharmacologic Prophylaxis of Atrial Fibrillation in Patients Undergoing Surgical Revascularization
Cardiovascular & Hematological Agents in Medicinal Chemistry Seq and You Will Find
Current Gene Therapy Kainic Acid-Induced Neurotoxicity: Targeting Glial Responses and Glia-Derived Cytokines
Current Neuropharmacology Synthesis of Novel 8-Hydroxy Quinolin Based 1,3,4-oxadiazoles and S-substituted 1,2,4-triazole Derivatives and Evaluation of their Anti-inflammatory, Analgesic, Ulcerogenic and Anti-Microbial Activities
Medicinal Chemistry Fc Engineering to Improve the Function of Therapeutic Antibodies
Current Pharmaceutical Biotechnology A Recent Update on Therapeutics to Treat Emerging n-COVID 19: A Review
Coronaviruses PKC-θ is a Drug Target for Prevention of T Cell-Mediated Autoimmunity and Allograft Rejection
Endocrine, Metabolic & Immune Disorders - Drug Targets Aqueous Extract of Arbutus unedo Inhibits STAT1 Activation in Human Breast Cancer Cell Line MDA-MB-231 and Human Fibroblasts Through SHP2 Activation
Medicinal Chemistry Chemical Mediators of Gallbladder Dysmotility
Current Medicinal Chemistry